Basal cell carcinoma with pulmonary and lymph node metastasis causing death

Archives of Dermatology

Volumn 139, Issue 5, 2003, Pages 643-648

  Robinson, June K ^a,b   Dahiya, Madhu ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b LOYOLA UNIVERSITY HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CD31 ANTIGEN; CD34 ANTIGEN; EPITHELIAL MEMBRANE ANTIGEN; PROTEIN BCL 2;

ADULT; ARTICLE; BASAL CELL CARCINOMA; CANCER RADIOTHERAPY; CASE REPORT; CLINICAL FEATURE; DEATH; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG METASTASIS; LYMPH NODE METASTASIS; MALE; MICROVASCULATURE; PRIORITY JOURNAL;

CARCINOMA, BASAL CELL; FATAL OUTCOME; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; SKIN NEOPLASMS;

EID: 0037616295     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.139.5.643     Document Type: Article

References (67)

1. Cotran RS. Metastasizing basal cell carcinoma. Cancer. 1961;14:1036-1040.
2. Paver K, Royser K, Burry N, et al. The incidence of basal cell carcinoma and their metastases in Australia and New Zealand [letter]. Australas J Dermatol. 1973;14:53.
3. Scanlon EF, Volkmer D, Oviedo MA, et al. Metastatic basal cell carcinoma. J Surg Oncol. 1980;15:171-180.
4. Weedon D, Wall D. Metastatic basal cell carcinoma. Med J Aust. 1975;2:177-179.
5. Lakshmipathi T, Hunt KM. Metastasizing basal cell carcinoma. Br J Dermatol. 1967;79:267-270.
6. Miller DL, Weinstock MA. Nonmelanoma skin cancer in the United States: incidence. J Am Acad Dermatol. 1994;30:774-778.
7. Hoy WE. Nonmelanoma skin cancer in Albuquerque, New Mexico: experience of a major health care provided. Cancer. 1996;77:2489-2495.
8. Zackheim HS. Origin of human basal cell epithelioma. J Invest Dermatol. 1963;40:283-297.
9. Brodland DG. Features associated with metastasis. In: Miller SJ, Maloney ME, eds. Cutaneous Oncology. London, England: Blackwell Science Inc; 1998:657.
10. Pinkus H. Epithelial and fibroepithelial tumors. Arch Dermatol. 1965;91:24-37.
11. Beadles CF. Rodent ulcer. Trans Pathol Soc Lond. 1894;45:176-181.
12. Giri DD, Gupta PK, Hoda RS. Cytologic diagnosis of metastatic basal cell carcinoma: report of a case with immunocytochemical and molecular pathologic considerations. Acta Cytol. 2000;44:232-236.
13. Osterlind A, Hjalgrim H, Kulinsky B, Frentz G. Skin cancer as a cause of death in Denmark. Br J Dermatol. 1991;125:580-582.
14. Amonette RA, Salasche SJ, Mc Chesney T, Clarendon CD, Dilawari RA. Metastatic basal cell carcinoma. J Dermatol Surg Oncol. 1981;7:397-400.
15. Dzubow LM. Metastatic basal cell carcinoma originating in the supra-parotid region. J Dermatol Surg Oncol. 1986;12:1306-1308.
16. Von Domarus H, Stevens PJ. Metastatic basal cell carcinoma: report of five cases and review of 170 cases in the literature. J Am Acad Dermatol. 1984;10:1043-1060.
17. Farmer ER, Helwig EB. Metastatic basal cell carcinoma: a clinico-pathologic study of 17 cases. Cancer. 1980;46:748-757.
18. Assor D. Basal cell carcinoma with metastasis to bone. Cancer. 1967;20:2125.
19. Wermuth BM, Fajardo LF. Metastatic basal cell carcinoma. Arch Pathol. 1970;90:458-462.
20. Soffer D, Kaplan H, Weshler Z. Meningeal carcinomatosis due to basal cell carcinoma. Hum Pathol. 1985;16:530.
21. Randle HW. Basal cell carcinoma: identification and treatment of the high-risk patient. Dermatol Surg. 1996;22:255-261.
22. Lo JS, Snow SN, Reizner GT, et al. Metastatic basal cell carcinoma: report of 12 cases and a review of the literature. J Am Acad Dermatol. 1991;24:715-719.
23. Snow SN, Sahl W, Lo JS, et al. Metastatic basal cell carcinoma: report of five cases. Cancer. 1994;73:328-335.
24. Menz J, Sterrett G, Wall L. Metastatic basal cell carcinoma associated with a small primary tumour. Australas J Dermatol. 1985;26:121-124.
25. Siegel RJ, Wood T. Nonrecurrent primary basal cell carcinoma of the lower extremity with late metastasis. J Dermatol Surg Oncol. 1994;20:490-493.
26. Mikhail GR, Nims LP, Kelly AP Jr, Ditmars DM, Eyler WR. Metastatic basal cell carcinoma. Arch Dermatol. 1977;113:1261-1269.
27. Safai B, Good RA. Basal cell carcinoma with metastasis. Arch Pathol Lab Med. 1977;101:327-331.
28. Otley CC, Lim KK, Roenigk RK. Cure rates for cancer of the skin: basal cell carcinoma, squamous cell carcinoma, melanoma, and soft tissue sarcoma. In: Roenigk RK, Roengik HH, eds. Dermatologic Surgery. New York, NY: Marcel Dekker Inc; 1996:745-753.
29. Asada M, Schaart FM, de Almeida HL Jr, et al. Solid basal cell epithelioma (BCE) possibly originates from the outer root sheath of the hair follicle. Acta Derm Venereol. 1993;73:286-292.
30. Kruger K, Blume-Peytavi U, Ortanos CE. Basal cell carcinoma possible originates from the outer root sheath and/or the bulge region of the vellus hair follicle. Arch Dermatol Res. 1999;291:253-259.
31. Van Scott EJ, Reinertson RP. The modulating influence of the stromal environment on epithelial cells studied in human autotransplants. J Invest Dermatol. 1961;36:109-117.
32. Lyles TW, Freeman RG, Knox JM. Transplantation of basal cell epitheliomas. J Invest Dermatol. 1960;34:353.
33. Blackwell JB, McComb H. The long-term results of autologous transplantation of basal cell carcinoma in skin grafts. Cancer. 1969;23:101-108.
34. Gerstein W. Transplantation of basal cell epithelioma to the rabbit. Arch Dermatol. 1963;88:834-836.
35. Cooper M, Pinkus H. Intrauterine transplantation of rat basal cell carcinoma as a model for reconversion of malignant to benign growth. Cancer Res. 1977;37:2544-2552.
36. Grimwood RE, Glanz SM, Siegle RJ. Transplantation of human basal cell carcinoma to C57/Balb/Cbg/bg-nu/nu (beige-nude) mouse. J Dermatol Surg Oncol. 1988;14:59-62.
37. Stough DB, Jimenez FJ. Single hair grafting. In: Roenigk RK, Roengik HH, eds. Dermatologic Surgery. New York, NY: Marcel Dekker Inc; 1996:1205-1211.
38. Srivastava A, Laidler P, Davies RP, et al. The prognostic significance of tumor vascularity in intermediate-thickness (0.76-4.0 mm thick) skin melanoma: a quantitative histologic study. Am J Pathol. 1988;133:419-423.
39. Weidner N, Semple JP, Welch WR, et al. Tumor angiogenesis and metastasis: correlation in breast carcinoma. N Engl J Med. 1991;324:1-8.
40. Bosari S, Lee AKC, De Lillis RA, et al. Microvessel quantitation and prognosis in invasive breast carcinoma. Hum Pathol. 1992;23:755-761.
41. Kaldjian E, Jin L, Lloyd R. Immunohistochemical analysis of breast carcinomas: correlation of oestrogen and progesterone receptors, proliferative activity, tumor vascularity, and lymph node metastasis [abstract]. Mod Pathol. 1992;5:14A.
42. Horak E, Leek R, Klenk N, et al. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet. 1992;340:1120-1124.
43. Weidner N, Carroll PR, Flax J, et al. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol. 1993;143:401-409.
44. Weidner N. Tumor angiogenesis: basic concepts and review of current applications in tumor prognostication. Semin Diagn Pathol. 1993;10:302-313.
45. Folkman J. What is the evidence that tumors are angiogenesis-dependent? J Natl Cancer Inst. 1990;82:4-6.
46. Liotta LA, Steeg PS, Stetler-Stevenson WG. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell. 1991;64:327-336.
47. Staibano S, Boscaino A, Salvatore G, Orabona P, Palombini L, De Rosa G. The prognostic significance of tumor angiogenesis in nonaggressive and aggressive basal cell carcinoma of the human skin. Hum Pathol. 1996;27:695-700.
48. Baum R. Expression of CD44 isoforms in basal cell carcinomas. Br J Dermatol. 1996;134:465-468.
49. Beer T. Ber Ep4 and epithelial membrane antigen aid distinction of basal cell, squamous cell and basosquamous carcinomas of the skin. Histopathology. 2000;37:218-223.
50. De Rosa K. Fibronectin, laminin, type IV collagen distribution and myofibroblastic stroma reaction in aggressive and nonaggressive basal cell carcinoma. Am J Dermatopathol. 1994;16:258-267.
51. Dumas L. Expression of basement membrane antigens and matrix metalloproteinaseses 2 and 9 in cutaneous basal and squamous cell carcinoma. Anticancer Res. 1999;19:2929-2938.
52. Fuller N. Expression of E-cadaherin in human epidermal non-melanoma cutaneous tumors. Br J Dermatol. 1996;134:28-32.
53. Giri J. Cytologic diagnosis of metastatic basal cell carcinoma: report of a case with immunocytochemical and molecular pathologic considerations. Acta Cytol. 2000;44:232-236.
54. Horlock NL. Cellular proliferation characteristics do not account for the behaviour of horrifying basal cell carcinoma: a comparison of growth fraction of horrifying and nonhorrifying tumours. Br J Plast Surg. 1998;51:59-66.
55. Kanatakis B. Expression of the nm23 metastatsis-supressor gene product in tumors. J Cutan Pathol. 1997;24:151-156.
56. Leffell DL. Aggressive-growth basal cell carcinoma in young adults. Arch Dermatol. 1991;127:1663-1667.
57. Lifschitz-Mercer B, Czernobilsky B, Feldberg E, Geigas B. Expression of the adherens junction protein vinculin in human and squamous cell tumors: relationship to invasiveness and metastatic potential. Hum Pathol. 1997;28:1230-1236.
58. de Faria J. Basal cell carcinoma of the skin with areas of squamous cell carcinoma: a basosquamous cell carcinoma? J Clin Pathol. 1985;38:1273-1277.
59. Maloney M. What is basosquamous carcinoma? Dermatol Surg. 2000;26:505-506.
60. Morales-Ducret CR, van de Rijn M, LeBrun DP, Smoller BR. Bcl-2 expression in primary malignancies of the skin. Arch Dermatol. 1995;131:909-912.
61. Pentel MJ. Cell surface molecules in basal cell carcinomas. Dermatol Surg. 1995;21:858-861.
62. Ramdial MP. Bcl-2 protein expression in aggressive and non-aggressive basal cell carcinomas. J Cutan Pathol. 2000;27:283-291.
63. Ratner D. Perineural spread of basal cell carcinomas treated with Mohs micrographic surgery. Cancer. 2000;88:1605-1613.
64. Rossen TT. Expression of the alpha 6 beta 4 integrin by squamous cell carcinomas and basal cell carcinomas: possible relation to invasive potential? Acta Derm Venereol. 1994;74:101-105.
65. Seelentag AG. Cd44 standard and variant isofrom expression in human epidermal skin tumors is not correlated with tumor aggressiveness but does appear regulated during proliferation and tumor de-differentiation. Int J Cancer. 1996;69:218-224.
66. Spiers MP. Expression of plasminogen activators in basal cell carcinoma. J Pathol. 1996;178:290-296.
67. Wagner R. Differential expression of tissue inhibitor metalloproteinases-2 by cutaneous squamous and basal cell carcinomas. J Invest Dermatol. 1996;106:321-326.